The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1 | Oncogenesis
HGF-gene transfection resulted in reducing susceptibility of EML4-ALK... | Download Scientific Diagram
Jinfukang induces cellular apoptosis through activation of Fas and DR4 in A549 cells
Supplemental Materials for BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer - Lung Cancer
AddexBio Product Detail - A431 Cells
Response to an HSP90 inhibitor in H3122/CR and H2228/TR cell lines. (A)... | Download Scientific Diagram
Crizotinib inhibits migration and expression of ID1 in MET-positive lung cancer cells: implications for MET targeting in oncology | Future Oncology
Phase‐separated foci of EML4‐ALK facilitate signalling and depend upon an active kinase conformation | EMBO reports
EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer - ScienceDirect
Cells | Free Full-Text | Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement | HTML
A B C Figure S1: Effects of onalespib combinations on body weight of mice bearing tumor xenografts Relative body weight change of mice bearing HCC827 (A), - ppt download
YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation | Nature Communications
EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer - ScienceDirect
EMT changes and resistance to ALK-TKIs in H2228 cells exposed to... | Download Scientific Diagram
Cell Lines Nci H2228 (ATCC) | Bioz | Ratings For Life-Science Research
Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data | Genome Biology | Full Text
Epithelial‐mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4‐ALK translocation - Kim - 2013 - Molecular Oncology - Wiley Online Library
Establishment of ALK-TKI-resistant H2228 cells. (A) H2228-CRR,... | Download Scientific Diagram
Cells | Free Full-Text | Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement | HTML
Epithelial-mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4-ALK translocation - ScienceDirect
Evaluation of EML4-ALK fusion proteins in non-small cell lung cancer using small molecule inhibitors. - Abstract - Europe PMC
Figure 3. | Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases | Cancer Research
A549/DDP Cell Line - EP-CL-0519 | Civic Bioscience
EML4-ALK V3 drives cell migration through NEK9 and NEK7 kinases in non-small-cell lung cancer | bioRxiv
Effect of PF-02341066 and radiation on non-small cell lung cancer cells
Cell Lines Nci H2228 (ATCC) | Bioz | Ratings For Life-Science Research
